TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KALVISTA PHARMACEUTI (KALV) insider trades

KALVISTA PHARMACEUTI (KALV) insider trading activity (SEC Form 4). Over the trailing 90 days, KALV insiders filed 0 purchases totalling $0 and 13 sales totalling $1.8M — net SELLING of $1.8M. Most recent filing: May 29, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
13
$1.8M
Net (90d)
-$1.8M
net selling
Most recent
May 29, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
May 29, 2026Yea ChristopherCHIEF DEVELOPMENT OFFICERS SaleOE—$26.78$905Kfiling
May 27, 2026Audhya Paul K.CHIEF MEDICAL OFFICERS SaleOE—$26.78$60Kfiling
May 27, 2026Sweeny NicoleChief Commercial OfficerS SaleOE—$26.78$40Kfiling
May 27, 2026Yea ChristopherCHIEF DEVELOPMENT OFFICERS SaleOE—$26.78$53Kfiling
May 26, 2026Piekos BrianCFOS SaleOE—$26.78$40Kfiling
May 26, 2026Sweeny NicoleChief Commercial OfficerS SaleOE—$26.78$50Kfiling
May 26, 2026Audhya Paul K.CHIEF MEDICAL OFFICERS SaleOE—$26.78$72Kfiling
May 26, 2026Palleiko Benjamin LCEOS SaleOE—$26.78$293Kfiling
May 26, 2026Yea ChristopherCHIEF DEVELOPMENT OFFICERS SaleOE—$26.78$63Kfiling
May 19, 2026Palleiko Benjamin LCEOS SaleOE—$26.76$30Kfiling
May 19, 2026Audhya Paul K.CHIEF MEDICAL OFFICERS SaleOE—$26.76$28Kfiling
May 19, 2026Yea ChristopherCHIEF DEVELOPMENT OFFICERS SaleOE—$26.76$30Kfiling
May 13, 2026Palleiko Benjamin LCEOS SaleOE—$26.71$89Kfiling